6-K

TOTAL VOTING RIGHTS

Company: Indivior Pharmaceuticals, Inc.
Filed: March 3, 2025
Period of Report: March 3, 2025
Accession Number: 0001654954-25-002190

View Document ↗ View on SEC.gov ↗